Onassis Holdings Corp. (OTC: ONSS) has multiple wellness products and brands in its portfolio with a focus on holistic health through CBD and Hemp Oil products and technology, giving the company potential that exceeds a single market. The company acquires and operates multiple influential businesses within the holistic health industry, is involved in white labelling, and has more developments on the way.
The compound is being utilized for its long list of potential holistic benefits, creating one of the fastest growing global markets: $47.22 billion by 2028 at a compound annual growth rate (CAGR) of 21.3%, and overlapping with a $404B holistic health market opportunity.
The Growing Value of Holistic Health
Onassis operates in a space worth hundreds of billions of dollars, giving the company strong potential for growth in its holistic health pursuits.
According to a 2021 report by Grandview Research, the market for complementary and alternative medicine (CAM) — one that can be described under the “holistic health” umbrella — is projected to register a CAGR of 22.03% through 2028 and reach $404.66 billion. Onassis doesn’t explicitly describe themselves as a CAM business, however their holdings do lie securely in that categorization, where public interest is shifting.
The core philosophies of alternative medicine and complementary therapies include strong preference for natural products over synthetic ones, an aversion to quick-fix therapies common in western healthcare practices, and a pursuit of overall, preventative health. Research shows that consumers agree, with a survey in the United States finding that 89% of consumers agree fortified food has health benefits beyond its nutritional value.
Select Onassis Holding Corp Products/Brands
Skincare products comprise a massive piece of the health and wellness pie, accounting for $213 billion globally by 2028 and registering a CAGR of 9.2%, according to Grandview Research.
Ananda Labs is a versatile company that specializes in CBD-based skincare products. The company develops a variety of products under its label, including CBD Stem Cells & Peptides Eye Contour Cream, CBD Concealer Repair Cream, CBD & Hyaluronic Facial PH Balance Toner, CBD & Hyaluronic Cleansing Milk, and more.
The company also oversees marketing operations of Extrax CBD vapes. The product provides broad-spectrum CBD Hemp extract combined with Cannabis derived terpenes, in high-quality vaping devices, without any stabilizers or additives of any sort, branded as a leading product for the "vaping smart" trend.
Learn More About Ananda
MGC Nutra is a subsidiary of Onassis which focuses on plant-based medicines, such as ArtemiC product line. The nutraceuticals market was reportedly worth $224 billion back in 2021 and expected to reach $365 billion by 2026 thanks to its CAGR of 10.23%.
MGC Nutra focuses on creating high-grade CBD products that can be used for overall wellness, such as water soluble supplements, pods, and more. MGC’s specific approach is to bring pharma standards to this relatively new CBD and nutraceuticals market, and it shares scientific information behind its research into CBD’s effectiveness and development of their products.
Learn More About MGC NutraPrivate Labelling
Onassis offers the most comprehensive private label CBD program available, with more than 100 products (scroll down to see catalog). Our products allows our clients to build consumer confidence in their brands with a full lineup of the most popular and compliant white label CBD and private label CBD products. All of the finished products are backed by high standards of quality, consistency and compliance. One of the products “Footnany” was featured on Oprah and sold 50,000 units as a direct result.
Sign Up to Invest
A Diversified Opportunity
Skincare products comprise a massive piece of the health and wellness pie, accounting for $213 billion globally by 2028 and registering a CAGR of 9.2%, according to Grandview Research.
The total Global Cannabidiol (CBD) Market is estimated to reach USD 47.22 Billion by 2028, up from USD 4.9 Billion in 2021, at a compound annual growth rate (CAGR) of 21.3%.
The nutraceuticals market was reportedly worth $224 billion back in 2021 and expected to reach $365 billion by 2026 thanks to its CAGR of 10.23%.
Onassis holds growing businesses in each category, positioning it for future success, given current trends.
SIGN UP FOR UPDATESDon’t Miss out on the Future of Wellness
Onassis is currently focused on distribution of nutraceuticals and herbal-based medications in the wellness sector, along with future plans for manufacturing new products for this market. It has begun working with the world's top nutrition experts for innovative manufacturing and marketing collaboration. The Company has selected products that passed in-vitro and in-vivo clinical studies of herbal and marine formulations utilized and documented by traditional and natural medicine in over thousand years to ensure that its ingredients are effective. With an eye on quality, its herbs are hand-selected and reasonably sourced only from authentic medicinal material cultivation areas, designed to be fully traceable from harvest to extract. Onassis is the future of nutraceuticals, don’t miss this chance to join in.
